Mirae Asset Global ETFs Holdings
SION

Mirae Asset Global ETFs Holdings’s Sionna Therapeutics SION Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$363K Buy
9,185
+270
+3% +$10.3K ﹤0.01% 2053
2025
Q4 		$367K Buy
8,915
+3,272
+58% +$124K ﹤0.01% 2043
2025
Q3 		$166K Sell
5,643
-1,104
-16% -$24K ﹤0.01% 2417
2025
Q2 		$117K Buy
+6,747
New +$88.4K ﹤0.01% 2523

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SION Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Sionna Therapeutics (SION) stake by 3% in Q1 2026, buying an estimated $10.3K and bringing the position to 9,185 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Mirae Asset Global ETFs Holdings first reported a position in SION in Q2 2025 and has held it in 4 quarters since. The position peaked at $367K in Q4 2025. 122 funds tracked by Wall St. Rank hold SION as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 9,185 shares of Sionna Therapeutics worth $363K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 270 Sionna Therapeutics shares in Q1 2026, an estimated $10.3K.
  • Sionna Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2053 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Sionna Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Mirae Asset Global ETFs Holdings's Sionna Therapeutics position peaked at $367K in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.